Traumatic hyphema in children: risk factors for complications.

OBJECTIVE To identify risk factors associated with higher rates of ocular complications in children with traumatic hyphema. METHODS Consecutive inpatient records from July 1990 through December 1997 were retrospectively reviewed for all children (aged < or = 18 years) who were admitted to the Wilmer Ophthalmological Institute, Baltimore, Md, within 48 hours of a closed-globe injury leading to hyphema. Data obtained included age, sex, race, sickle cell status, initial and final visual acuities, hyphema size and intraocular pressure at presentation, the occurrence of a secondary hemorrhage, subsequent intraocular pressure elevations, and therapeutic interventions. RESULTS Forty children fulfilled the inclusion criteria: 20 African American, 1 Asian American, and 19 white. Five of the 20 African American children had sickle cell trait, and 1 had sickle cell anemia. The rate of secondary hemorrhage was statistically higher in the African American population (P =.05), but no statistical difference existed between the rate of secondary hemorrhage in patients with and without sickle cell hemoglobinopathy. Sickle cell hemoglobinopathy was associated with a higher intraocular pressure at presentation (P =.03) and during inpatient follow-up (P =.02). CONCLUSIONS In the setting of traumatic hyphema, African American children appear to be at greater risk for developing a secondary hemorrhage. In our patients, sickle cell hemoglobinopathy increased the risk of intraocular pressure elevation, but did not seem to increase the risk of rebleeding beyond that associated with race. Larger studies are needed to validate these observations.

[1]  A. Rajaeefard,et al.  An analysis of risk for secondary hemorrhage in traumatic hyphema. , 1999, Ophthalmology.

[2]  B. Rahmani,et al.  Comparison of tranexamic acid and prednisolone in the treatment of traumatic hyphema. A randomized clinical trial. , 1999, Ophthalmology.

[3]  M. Lucarelli,et al.  Traumatic hyphema: outcomes of outpatient management. , 1998, Ophthalmology.

[4]  P. Williams,et al.  Topical aminocaproic acid in the treatment of traumatic hyphema. , 1997, Archives of ophthalmology.

[5]  N. Kerr,et al.  Sickle cell trait as a risk factor for secondary hemorrhage in children with traumatic hyphema. , 1997, American journal of ophthalmology.

[6]  J. Jacob,et al.  Clinical evaluation of aminocaproic acid for managing traumatic hyphema in children. , 1995, Ophthalmology.

[7]  L. P. Fong,et al.  Secondary Hemorrhage in Traumatic Hyphema: Predictive Factors for Selective Prophylaxis , 1994 .

[8]  A. Rosenthal,et al.  Factors related to the incidence of secondary haemorrhage in 462 patients with traumatic hyphaema , 1992, Eye.

[9]  P. Kearns,et al.  Traumatic hyphaema: a retrospective study of 314 cases. , 1991, The British journal of ophthalmology.

[10]  J. Bloom Traumatic hyphema in children. , 1990, Pediatric annals.

[11]  T. Spoor,et al.  Traumatic hyphema in an urban population. , 1990, American journal of ophthalmology.

[12]  R. Brubaker,et al.  Traumatic hyphema in a defined population. , 1988, American journal of ophthalmology.

[13]  S. Kraft,et al.  Traumatic hyphema in children. Treatment with epsilon-aminocaproic acid. , 1987, Ophthalmology.

[14]  S. Weisman,et al.  Aminocaproic acid reduces the risk of secondary hemorrhage in patients with traumatic hyphema. , 1987, Archives of ophthalmology.

[15]  W. Feuer,et al.  Rebleeding after traumatic hyphema. , 1986, Archives of ophthalmology.

[16]  R. Anderson,et al.  A comparison of two dose regimens of epsilon aminocaproic acid in the prevention and management of secondary traumatic hyphemas. , 1986, Ophthalmology.

[17]  R. Marks,et al.  The incidence of rebleeding in traumatic hyphema. , 1985, Annals of ophthalmology.

[18]  G. H. Cassel,et al.  Wills Eye Hospital Traumatic Hyphema Study. , 1985, Ophthalmic surgery.

[19]  R. Weinreb,et al.  Indications for surgical management of hyphema in patients with sickle cell trait. , 1984, Archives of ophthalmology.

[20]  M. Goldberg,et al.  Aminocaproic acid decreases secondary hemorrhage after traumatic hyphema. , 1983, Archives of ophthalmology.

[21]  M. Goldberg,et al.  Sickled erythrocytes, hyphema, and secondary glaucoma: I. The diagnosis and treatment of sickled erythrocytes in human hyphemas. , 1979, Ophthalmic surgery.

[22]  M. Goldberg,et al.  The diagnosis and treatment of secondary glaucoma after hyphema in sickle cell patients. , 1979, American journal of ophthalmology.

[23]  Skalka Hw Recurrent hemorrhage in traumatic hyphema. , 1978 .

[24]  H. Skalka Recurrent hemorrhage in traumatic hyphema. , 1978, Annals of ophthalmology.

[25]  E. Crouch,et al.  Aminocaproic acid in the treatment of traumatic hyphema. , 1976, American journal of ophthalmology.

[26]  M. Goldberg,et al.  Comparison of medical treatment for traumatic hyphema , 1974 .

[27]  Gilbert Hd,et al.  Atropine in the treatment of traumatic hyphema. , 1973 .

[28]  H. Gilbert,et al.  Atropine in the treatment of traumatic hyphema. , 1973, Annals of ophthalmology.

[29]  M. Greenberg,et al.  A simple and inexpensive screening test for sickle hemoglobin. , 1972, The New England journal of medicine.

[30]  P. Thygeson,et al.  Observations on traumatic hyphema. , 1952, American journal of ophthalmology.